REYON Pharmaceutical Co., Ltd. (102460.KS) KSC

11,090.00

+40(+0.36%)

Updated at October 20 10:48AM

Currency In KRW

REYON Pharmaceutical Co., Ltd.

Address

416 Yeongdong-daero

Seoul,

Korea, Republic of

Phone

82 2 793 5557

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Employees

448

First IPO Date

June 10, 2010

Key Executives

NameTitlePayYear Born
Ms. Soon-Ock JungChairman & Chief Executive Officer01950
Yong-Hwan YooPresident, Chief Executive Officer & Representative Director01974
Hung-Muk ChoiExecutive Director0N/A

Description

REYON Pharmaceutical Co., Ltd. manufactures and sells finished medicines and APIs in South Korea and internationally. The company offers its products under the areas of adrenal corticosteroides; angiotensin II receptor antagonists; anticholinergics; antiemetic; antihypertensives; anti-inflammatory enzymes; antilipidemic, antirheumatic, and oral hypoglycemic agents; anti-peptic ulcer; antispasmodics; benign prostatic hypertrophy; cough and cold remedies; cardiac stimulant; genitourinary smooth muscle relaxants; hemostatics; immunosuppressants; rheumatoid arthritis; local anesthetics; migraine drugs; miscellaneous cardiovascular system drugs; neuromuscular disorder related drugs; nootropics and neurotonics; NSAIDs; respiratory stimulants; skeletal muscle relaxants; and vasodilators. REYON Pharmaceutical Co., Ltd. was founded in 1955 and is headquartered in Seoul, South Korea.